Exonic
Exonic is a YC Fall 2025 (F25) company. Based in San Francisco, CA, USA. Team of 3.
About Exonic
Summary
Exonic builds an open, crowdsourced drug discovery platform that lets researchers worldwide combine biological AI models, design workflows, and run computational experiments without writing code. It targets the closed, institution-siloed structure of traditional drug discovery, replacing proprietary internal pipelines with a meritocratic tournament model where anyone can contribute. The platform includes a wet lab validation layer, as demonstrated by a benchmark result in synthetic enhancer design for liver cancer.
Business model
Not specified in available sources.
Go-to-market
The platform is self-serve and open to anyone, from professional researchers to independent contributors, with no coding required to get started.
From the Y Combinator listing
Crowdsourcing drug discovery.
Exonic is building a global network of intelligence to cure disease. We are the first drug discovery company open to everyone. Today drug discovery is siloed - secretive, adversarial institutions in glass towers. Biological AI is changing the rules. Every day drug discovery becomes more of a computational problem. Exonic is turning drug discovery into an open, meritocratic tournament. We are advised by world leaders in bio AI, including the former Head of AI at Ginkgo Bioworks, and the first author of Evo (cover of Science). All of the best biological AI models are open source. And on Exonic, you can combine them, prompt them, and share your innovative workflows without writing a single line of code. Using Exonic Studio, we just beat a state-of-the-art benchmark in liver cancer (HepG2) synthetic enhancer design, validated in our wet lab. The platform just went live - you can start right now. We are turning the internet into a drug discovery powerhouse.
Facts
- Healthcare / Healthcare -> Drug Discovery and Delivery
- San Francisco, CA, USA
- 3
- Active
- Early
Founders (1)
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works